Old National Bancorp’s Novavax NVAX Stock Holding History

Old National Bancorp’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-25	Closed	-$4K	–	719
2015 Q1	$4K	Buy	+25	New	+$4.06K	﹤0.01%	752

Other funds holding NVAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Old National Bancorp's NVAX Position: Q2 2015 in Review

Old National Bancorp sold out of Novavax (NVAX) in Q2 2015, closing a stake of 25 shares — an estimated $4K sold.

Old National Bancorp first reported a position in NVAX in Q1 2015 and held it in 1 quarter. The position peaked at $4K in Q1 2015. 159 funds tracked by Wall St. Rank hold NVAX as of Q2 2015.

Old National Bancorp reported no remaining Novavax position as of Q2 2015 after selling out during the quarter.
Old National Bancorp sold 25 Novavax shares in Q2 2015, an estimated $4K.
Old National Bancorp first reported a position in Novavax in Q1 2015 and held it in 1 quarter.
Old National Bancorp's Novavax position peaked at $4K in Q1 2015.
159 funds tracked by Wall St. Rank held Novavax as of Q2 2015.

Based on Old National Bancorp's 13F filing for Q2 2015, filed 17 Aug 2015.